Publication | Closed Access

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

VaccinationVaccine SafetyVaccine DevelopmentClinical TrialsVirologySeronegative AdultsVaccine EfficacyMedicineVaccine ResearchFlavivirusCovid-19